siRNA, Anti-SLC17A4, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT31502WQ-2OMe)

The product SIRGT31502WQ-2OMe is a type of small interfering RNA (siRNA) that targets SLC17A4 gene and regulates the expression of gene. The siRNA interferes with the expression of SLC17A4 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001286121.1; NM_005495.2
Alternative Names KAIA2138
Related Diseases kidney disease
Purification HPLC
Target Gene
Gene ID 10050
Uniprot ID Q9Y2C5
Sub Cat Target Species Modification Scale  
SIRGT32502WQ-2F SLC17A4 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT33502WQ-2MOE SLC17A4 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT34502WQ-LNA SLC17A4 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT31502WQ-RB SLC17A4 Human Ribo-modified Inquiry
SIRGT32502WQ-BB SLC17A4 Human Backbone-modified Inquiry

Related Products